Prevalence of HCV in rural Menoufyia
16th International Conference on Oncology Nursing and Cancer Care
April 15-16, 2019 | Frankfurt, Germany
Basem Mohamed Saleh
Menoufyia University, Egypt
Posters & Accepted Abstracts : J Med Oncl Ther
Abstract:
Objectives and Background: Egypt has the highest
known prevalence of HCV in the world. With a
current endemic attributed to the mass Schistomiasis
treatment campaigns in the last century. The
problem represents a major challenge to healthcare
policymaker that hinders many development plans
in the country. In this study, we aimed to highlight on
the prevalence of HCV infection in rural Menoufia and
examine the association between different variables
and the seropositivity of HCV in our studied sample.
Methods: A screening campaign was conducted in
five villages present in rural Menoufia. Blood samples
from consented participants were tested for HCV
Antibodies using Enzyme-Linked immunosorbent
Assay “ELISA”. For assessment of the contribution
to different risk factors to our results, our team
interviewed the participants to complete the study
developed questionnaire. Results were analyzed and
Chi-Square test was used to assess the significance
of associations in most of the study variables.
Results: Out of 1615 participants, 21.9% “n=354”
of the screened sample tested positive for HCV
antibodies. Various risk factors were significantly
associated with higher risk for having HCV including
parentral anti-schistosomiasis therapy, blood
transfusion and invasive medical preosedures.
Conclusion: One of each five in the population of
rural Menoufia is seropositive for HCV. Our results
thus confirms the severity of the current disease
burden in the Nile Delta of Egypt. The association
found between different risk factors and the state of
seropositivity adds to evidence suggesting the need
for more strict infection control measures upon
using invasive medical procedures.
Biography:
E-mail:
dr.basemsaleh@yahoo.comPDF HTML